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The term hypomelanosis ofIto has been used as a diag­
nosis for individuals with hypopigmentation or depig­
mentation distributed along the lines of Blaschko. , 
Approxim,ately half of these patients have had neuro­
logic, skeletal, and/or ocular abnormalities. In many, 
determination that the lighter areas of skin were hypo­
pigmented rather than the darker areas hyperpig­
mented has been arbitrary. Evidence documenting 
single-gene transmission is unconvincing and recur­
rence risks appear to be negligible in most instances. 
Karyotyping of blood lymphocytes, skin fibroblasts, 
and/or keratinocytes oftts individuals reported in the 
literature revealed abnormal chromosome constitu­
tions in 60. Three patients were 46;KX/46;XY chi­
meras, two were 46,xx/46,xx chimeras. Most pa-
I n 1951, MinorIto [1] described a young woman with exten­sive leukoderma distributed in a splash-like, swirly pattern, along the lines ofBlaschko [2]. H e  coined the term incontin­entia pigmenti achromians (IP A) because the pattern of color loss was similar to that of the hyperpigmentation of incon­
tinentia pigmenti, an x-linked dominant disorder. In 1973, Jelinek 
[3] used the term hypomelanosis ofIto (HI) as a diagnostic appella­
tion for patients with hypopigmentation or depigmentation in the 
same pattern. More than half of the case reports of HI and IP A have 
described a host of associated abnormalities, some of which are 
shared in common by many patients, others of which are distinct 
and unique. 
Several modes of inheritance have been proposed, all based on 
single case reports [4-12]. 
MATERIALS AND METHODS 
Reports [13 -15] of patients with mosaicism for chromosome abnormalities 
who had the skin changes of hypomelanosis of Ito promJ'ted us to initiate a 
recall of all of our patients who carried a diagnosis of HI L 16). We attempted 
to karyotype both lymphocytes and fibroblasts from each. Whenever possi­
ble , more than one skin biopsy was obtained, either &om each side of the 
body or from both a light and dark area. At least 50 cells were examined from 
each sample. In addition, I have reviewed the English, French, Italian, and 
Spanish medical literature to determine the proportion of patients with 
variegate pigmentation in whom cytogenetic abnormalities were sought and 
found. I have also critically reviewed all reports of transmission of HI to 
offspring, to assess the likelihood of single gene transmission [17]. 
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tients were mosaic for aneuploidy or unbalanced 
translocations, with two or more chromosomally dis­
tinct cell lines either within the same tissue or between 
tissues. The more common alterations included mosaic 
trisomy 18, diploidy/triploidy, mosaicism for sex 
chromosome aneuploidy, and tetrasomy 12p. Karyo­
typing of blood and, if necessary, skin, to detect mosai­
cism is warranted in all patients presenting with swir­
ley pigmentary changes, either hyperpigmentation or 
hypopigmentation. The terms hypomelanosis of Ito 
and incontinentia pigmenti achromians should be 
abandoned as they are neither diagnostic nor specific. 
Key words: ,ncontinentia pigmenti achromiam / chromosomal 
mosaicism/genetia. ] In"at Dermatol 103:141S-143S, 
1994 
RESULTS 
Chromosome Studies Of the 13 patients .recalled, cytogenetic 
studies were possible in 12. Of these, eight were found to have 
chromosomal alterations (Table I). Six were mosaic, with two or 
more chromosomally distinct cell lines. Two patients had aneu­
ploidy without evidence for mosaicism, but only lymphocytes were 
studied in these two. 
Including our study, cytogenetic evaluation has been undertaken 
in 116 of 220 individuals discussed in 77 publications (Tables 1-
m). Of these, 58 (50%) were either mosaic for aneuploidy or were 
chromosmallyabnormal in all cells studied. In 45 patients, only one 
tissue was studied. Sixteen (38%) of these were aneuploid. of 70 
instances where both blood and skin were studied, 42 individuals 
(60%) had chromosome abnormalities. In one of these, mosaicism 
was found only in cultured keratinocytes. Eighteen patients were 
mosiac or abnormal in skin only, one was abnormal in blood only, 
and 22 were abnormal in both. 
Chromosomal alterations reported with some frequency in­
cluded mosaicism for tetrasomy 12p (Teschler-Nicola/Killian syn­
drome), mosaicism for trisomy 18, diploidy/triploidy, 45,X/ 
46,X,r(X) or 45,X/46,X, + mar and 46,XX/46,XY chimerism. 
An additional two patients, not included in the total of those 
with cytogenetic abnormalities, demonstrated chimerism for two 
normal 46,xx cell lines derived from fusion of two separate zy­
gotes. 
Mendelian Transmission There have been eight purported in­
stances of single gene inheritance of hypo melanosis of Ito. Two of 
these were missed diagnoses of incontinentia pigmenti [4,5,7 ]. One 
report of a man with HI described his daughter who had a reduction 
defect of one leg and no pigment changes [6]. This paper has been 
repeatedly cited as demonstrating autosomal dominant or sex­
linked dominant transmission of HI, despite the authors' explicit 
statement that the daughter's defect was unrelated to HI. A three­
paragraph -long transcript of a case presented at a meeting described 
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Table I. Karyo�es of Eight Patients with 
Hypomelanosis 0 Ito (modified &om [15]) 
Sex ABe Result T"_ 
Female 3 years 46,x,t(X;22)(qll.2;qI3.3) balanced. parents notmal L 
Female 13 months 46,xx,r(10) L 
Female 21 month. 45,xx.t(15;22)/46,xx L 
Female Birth 45.x/ 46.x. +ring L 
Male 18 years 47,xv.+18/46.XY L,SF 
Fema1e 3 years 46,xx L 
46,xx/46,XX,de1(13)(qll) SF 
Male 11 years 46,xv L 
46,xv /69,xxy SF 
Male 15 years 46.xy L 
46.xY/47.XY.+i(12p) SF 
• L.lymphoeytes; SF •• kin fibroblasts. 
a grandfather, mother, and son with pigment loss [8]. However, the 
mother's lesion involved only her leg and underwent repigmenta­
tion, suggestive of vitiligo. onet
E
digree presented in support of 
autosomal dominant inheritance 9] was based on historical report­
ing by the proband with no co tion by examination of pur­
portedly affected relatives, in none of whom were the skin changes 
described typical for HI. Three reports of isolated cases of HI within 
sibships born to consanguineous parents have been cited as proof of 
autosomal recessive inheritance [10-12]. No recurrences were 
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noted in siblings. Two of the families were from Pakistan and Iran, 
areas where baseline consanguinity rates are high. In such popula­
tions consanguinity does not provide compelling evidence for auto­
somal recessive inheritance [18]. 
CONCLUSIONS 
Hypomelanosis ofIto is a term that is descriptive and non-specific. It 
has been applied to individuals with diffuse, patchy, generalized, 
limited, or spotty depigmentation or hypopigmentation. It should 
be abandoned as it continues to cause confusion. 
Patients presenting with hypopigmentation, depigmentation, or 
hyperpigmentation distributed along the lines of Blaschko, or in 
any other patchy configuration, in the absence of a recognized diag­
nosis such as piebaldism, Waardenburg syndrome, or incontinentia 
pigmenti, should be karyotyped. 
Lymphocytes should be evaluated first, followed by fibroblast 
cultures of more than one skin biopsy if the blood is karyotypically 
normal. If feasible, keratinocyte culture and karyotyping may yield 
useful results. 
Prognosis depends upon the nature of the aneuploidy. Published 
series of patients are not helpful in regard to the risk for associated 
malformations or mental retardation as these compilations reflect 
fruit salad, i.e., heterogeneity, not the many manifestations of a 
single entity. 
Single-gene inheritance may be a cause in some patients with 
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Result 
45.xY.�14q21q)/46,xv.+t(14q21q)+mar 
46,xx.+t 2;8)(q37.2;p21.1) 
46.XY/47,xv.+18 
46.XY/47,xv.+rmr 
46,xx...,.(2;10) (L) 46,XX,ra(2;10)/47,xx. +22 (SF) 
46.XX/47,xx.+G group 
47,xx.+18 (L) 46,xxf47,xx.+18/47,xx.+13 (SF) 
46,xx.del(15q) mother 
46,xx.del(15q) daughter 
46,xv /47,xv.+t 
45.x/46,xx 
46,x,+t(X;IS) 
46,xv.9'" ,2q+ 
46,xv/47,xv.+t8 
46.xx!47,xx.+t8 
46,JCY/47,xv.+18 
46,xx/45,xx.-14/46,xx� .. uclic14qf46.xx.r(14) 
45.x (L) 4S.x/46.x,del(X) SF) 
47.xYY/48.xYY.+8 (L) 48.xYY,+8 (SF) 
46,xx/46,xx.4p+ 
46,xxf46,xx.18p (L) 46,xx.18p (SF) 
45.x/46.JC.rM 
46,xv ,deJ(2)(q32.2q33.1) 
46.xx!46,xx chimesa 
46,xx/46,xx chimera 
46,xx/47.xy chimera 
46.XX/46.XY chimera 
46,xx/46.xy chimera 
4S.x/46.x+r(X) 
46,JCY /47 ,xv.+i(I2p) 
46,xx/47.xx. +i(12p) 
46,xx/69,xxx 
46,xv.-1S.+r(ISq;15q)mat(ISql3-lCeD-+1Sq26) 
46.xy / 46.xY,r(22) 
46,xx/69,xxx 
46,xx/47,xx+t8 
46.x.+t(X;18�II;q23) 
45.x (L) 45.x 46,xv (SF) 
4S.x/46.XY 
46,xv/47,xv.+8q-
46,xx. +t(X;17)(ql3;pI3) 
46.xx!69,xxx 
46,xx/69,xxx 
46,xx/69,xxx/92,xxxx 
45.x/46.x.+r(X) 
46,xx/46,xx. -15.+t(14; 15) 
46,xv /92.xxYY/47,xv.+t8 
46,xxf46.,XX,del15ql 
46,xv /46,xv.+7 
46.xx!46,xx.-13 ...... 
46.xx!46.xx!47,xx.+7 
46.xx/45.x 
'Hyperpigmentation in patchy distribution. NO. not done; L.lymphocyte; SF. skin fibroblasts. 
'All ..... N1ly described in Am] Hum Gtnet 45: 193 -205. 1989. 
'Not induded in total of chromosomaiiy ab .......... patiaaa. 
"Fibroblull ud/or�. 
L/SF Reference 
+/ND Brai. Dtv 7:45-49. 1985 
+/ND Neuro/35:607 -610, 1985 
+/+ ] Ms1 Gt:nel 20:135-137. 1983 
-/+ ] Clift Dysmt>rp/tDl :2O-24. 1983 
+/+ A .. ]Ms1Gt:nel23:739-749.1986 
-/+ AM] Ms1 Gt:nel 23:739-749. 1986 
+/+ AMl Ms1 Gt:nel16:131-136. 1983 
+/ND Op th.lmologica 200:1-6. 1990 
+/NO Ophlh.lmologica 200:1-6. 1990 
-/+ Ophlh.1 Paediatr 11:273-279. 1990 
+/ND Dtvel Mtd Child Neurol 33:737 -743. 1991 
+/ND PaIWr DmMtoI9:1-10. 1992 
+/ND Pel;." n.m..IDl 9:1-10. 1992 
+/+ Clm Gt:nel 39:68-74. 1991 
+/+ CIllo Gt:nel39:68-74. 1991 
+/+ Am]Ms1 Gtnet 35:422-424. 1990 
+/+ Am] Hum Genet 45:193-20S. 1989' 
+/+ Lancet 11:343, 1986' 
+/+ Pedlalr Reo 21 :294A, 1987' 
+/+ Pro, G .... wood Genet Clr 6: 105. 1987' 
+/+ Pro< GrrnIlltlDd Gm<t Or 6:105, 1987' 
+/+ A .. ] Hum Gt:nel37:A93. 1985' 
+/+ ]Ms1Gt:nel26:127-140.1989 
+/ND B,] DmMtoIl03:489-498. 1980 
+/+ Br]DemtatoII03:489-498.1980 
NO/+ Am] Hum Genet 16:38-51. 1964 
+/+ CII. Genet 15:89-96. 1979 
-/+ Am] Hum Genet 19:378-387.1967 
ND/+ La.",,11:343. 1986 
-/+ Birth D{(OAS)XllJ(3B):103-110. 1m 
-/+ Birth D{(OAS)XDI(3B):103-110. 1m 
-/+ An. Gt:nel26:229-233. 1983 
+/- Am] Ms1 Gm<t 14'.307-314. 1983 
+/- Am] Mtd G".,3S:14-17. 1990 
-/+ Clin GtneI 39:370-375. 1991 
+/+ Am] Mtd Gen.t 45:120-121 , 1993 
+/+ Am]Med Genet 40:447-448.1991 
.� +/+ Am]Hu .. GattI 45:193-205. 1989 +/+ Am] Hu .. Gt:nel 45:193-205.1989 
+/+ D<fIJMs1C1tIMN .. ..r33:737-743. 1991 
+/+ Hum Gm<t 90:611 -613, 1993 
-/+ ] Ms1 Gt:nel25:809-818. 1988 
-/+ Lancet 1:1443-1444.1986 
-/+ Cli. Genet 41 :309-314. 1992 
+/NO Ptdialr n.m..tol 9:1-10. 1992 
+/+ Am] Mtd Genet 22:333-342. 1985 
+/+ CytogmdI<s 10:305-317.1971 
+/ND Hum Gm<t 74:185-187. 1986 
-/+ ] Med Gm<t 30:783-784.1993 
-/+ ] Ms1 Gt:nel 3O:752-75S. 1993 
-/+' ]Ms1 Gt:nel 3O:752-7S5 , 1993 
-/� ] Mtd G .. <l30:752-755, 1993 
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Table m. Case Reports orm 
Acto PlWliotr Scarul77:446-447, 1988 
AmJ Hum Gmet 1 6:38 -5 1 , 1964 
AmJ Hum Genet 19:378 -387, 1967 
Am J Hum Genet 37:A93, 1985' 
AmJ Hum Genet 45:193 -205, 1989-
AmJ Med Genet 14:307 -314, 1983 
AmJ Med GmeJ 16:131-136,1983 
AmJMedGmtt22:333-342,1985 
AmJMedGenet23:739-749,1986 
AmJ Med Gmet 35:14-17, 1990 
AmJMed Gmet 35:422-424, 1990 
Am J MeJ Genet 40:447 -448, 1991 
AmJ Med Genet 45:120-121,1993 
Ann Genet 26:229 -233, 1983 
Ann Genet 34:30-32, 1991 
Arch Dermoto/ l05:424-425, 1972 
Arch Dermato/l06:884-885, 1972 
Arch Dermato/l07:596-601, 1973 
Arch Dermatoll09:416, 1974 
Arch Dermoto/l11:751-756, 1975 
Arch Dermato/119:391-395, 1983 
Arch Dis Childh 56:798 -800, 1981 
AustralllSJ Dermato/33:97 - 10I , 1992 
Birth D{(OAS}XIII(3B}:103-110, 1977 
Brain Dev 7:45-49, 1985 
Br J Dermoto177:397 - 420, 1965 
Br J Dermatoll03:489-498, 1980 
Br J PllISt Surg 37:472-476,1984 
Bull Soc Pranc Dermotol Syph 76:553 -555, 1969 
Con] Neurol Sci 15:124-129,1988 
Ckft Palor.J 16:358-362,1979 
Clin Genet 15:89-96, 1979 
Clin Gmet 21:65-68,1982 
Clln Genet 34:109 - 115, 1989 
Clin Gmtt 39:68-74, 1991 
C/in Gmtt 39:370-375,1991 
Clin Gmtt 41:309-314, 1992 
Cutis 6:197-201,1970 
Cytogenetics 10:305-317, 1971 
Dermotol"iica 142:65-78 , 1971 
Devel Mel Child Neuro/33:737 -743, 1991 
Bur Neuro/31:345-347, 1991 
Gmtt c.uns 4:63-67, 1993 
Hum Gmet 74:185-187, 1986 
Hum Genet 90:611-613,1993 
lad PeJiatr 25:1000-1002, 1988 
IntJ Dermato/31:284-285, 1992 
Jpn J Dermotol B 73:303, 1963 
JpoJ Psych Neuro/44:414, 1990 
JAm Aead Dermato/4:194-204, 1981 
JCli. Dysmorpha/l:20-24, 1983 
J Comp Asst Tom 14:981-983, 1990 
J Med Genet 17:151 - 152, 1980 
JMedGenet20:135-137,1983 
J MeJ Genet 23:739-749,1986 
J MeJ Genet 25:809-818, 1988 
J Med Genet 26:127 -140, 1989 
JMed Genet 30:752-755,1993 
J Med Gmtt 30:783-784, 1993 
J Pediolr 90:236-240,1977 
J PeJiatr 115:75-80, 1989 
J PeJiatr 1 16(4}:581 -586, 1990 
J ped Ophthal Strah 28:160-163, 1991 
Lancet 1:1443-1444, 1986 
LaOeel 11:343, 1986-
Neuro PeJiatr 20:234 -237, 1988 
Neuro/ 35:607 -610, 1985 
Ophthalmologica 200:1-6,1990 
Ophthal PlWliatr 11:273-279, 1990 
Ophthal PIWl Genet 12:23-30, 1991 
Pediatr DermatoI7(1}:74-75, 1990 
peJiatrDermatoI9:1-10, 1992 
Ped RaJio/ 20:104 - 106, 1989 
Pedialr Res 21:294A, 1987' 
Proc C ..... ,.",.J Gmtl Ctr 6:105, 1987' 
&11 01 Pedialr 7:5-23, 1970 
TohakuJ&PMed(suppl} 55:57-59,1952 
'All case, fully described in Am] Hum Genet 45:193-205, 1989. 
pigmentary abnormalities. but that remains to be convincingly 
demonstrated. Recurrence risks in the absence of a familial chromo­
some translocation are negligible. 
The cause of the pigment alteration remains obscure and. to 
date. no satisfying explanation has emerged. The light and dark ap­
pearance may reflect the juxtaposition and contrast of two cell 
lines with different but normal pigment production (e.g .• chimeras). 
It may be caused by the loss or gain of genes that control pigment 
production and control may reside outside the melanocyte: in the 
autonomic nervous system. in the keratinocyte. in the dermis. in 
the epidermal appendages. in dermal-epidermal interactions, in 
hormone production, etc. [19]. The inability to demonstrate two 
different cell lines consistently from biopsies of light and dark 
areas may be due to the fact that only fibroblasts are cultured, and 
the cellular processes responsible for pigment production may lie 
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elsewhere. Chromosomal mosaicism in cultured keratinocytes that 
was not present in lymphocytes or fibroblasts has been demon­
strated. The abnormal cell lines were seen in keratinocytes from 
hypopigmented skin, and not in those from the normally colored 
skin [20]. 
In my opinion, multiple reports of isolated aspects of the same 
patient in different journals, especially without mutual citation, 
poison the data and should be prohibited. 
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